The MELISA Medica Foundation is dedicated to the science of metal allergy and its diagnosis when treating chronic diseases such as chronic fatigue syndrome (CFS or ME), multiple sclerosis (MS) or other autoimmune and allergic diseases.
The MELISA test is the only scientifically-proven blood test which diagnoses metal allergy to multiple metals. It was originally developed for the diagnosis of occupational allergies at Astra Pharmaceuticals (now AstraZeneca).
Every two years, the foundation organises an international conference; The MELISA Study Group.
It is a not-for-profit organisation with three aims:-
- To use the MELISA technology for research to examine the role of metals in chronic diseases.
- To help explain and promote the field of metal allergy through conferences and research.
- To persuade a charity or government that this technology, which has been successfully used on thousands of patients, represents a breakthrough in treating diseases like CFS and MS. The science is proven; MELISA is waiting to be put to the test.
The MELISA Foundation’s directors include Dr Dagmar Magnusson, one of the world’s leading experts in amalgam removal and metal-free dentistry, and Dr Birgitta Brunes, a general practitioner, who herself recovered from multiple sclerosis and has written about her experience.
Below is a list of all the MELISA Study Groups organised so far:
1st 1996: Ennstal, Austria
2nd 1996: Stockholm, Sweden
3rd 1997: Zürs am Arlberg, Austria
4th 1997: Stockholm, Sweden
5th 1997: Bad Emstal, Germany
6th 1998: Stockholm, Sweden
7th 1999: Antwerpen, Belgium
8th 2002: Padenghe Sul Garda, Italy
9th 2002: Estavayer-le-Lac, Switzerland
10th 2002: Hasselt, Belgium
11th 2004: Stockholm, Sweden
12th 2005: Prague, Czech Republic
13th 2007: Bremen, Germany
14th 2009: Valencia, Spain
15th 2011: Thessaloniki, Greece